1Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines ( Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation ): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[ J]. Circulation,2006, 114(7) : e257 -354.
2Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences(Committee to develop guidelines for the management of patients with atrial fibrillation ) developed in collaboration with the North American Society of Pacing and Electrophysiology[ J]. Eur Heart J,2001,22(20) : 1852 - 1923.
3Chiladakis JA, Kalogeropoulos A, Patsouras N, et al. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter[J]. J Am Coll Cardiol, 2004,44:859 -863.
4Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators[J]. N Engl J Med, 2000,342:913 -920.
5Singh S, Zoble RG, Yellen L, et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study[ J]. Circulation ,2000,102:2385 - 2390.
6Capucci A, Villani GQ, Piepoli MF. Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation[J]. Am J Cardiol,2003,92: 1345 - 1347.
7Torp-Pedersen C, Moiler M, Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction.Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group[J]. N Engl J Med, 1999,341:857 -865.
8Knight BP, Gersh BJ, Carlson MD, et al. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society[J]. Circulation, 2005,111:240 -243.
7Yamreudeewong W, Debisschop M, Martin LG,et al. Poten tially significant drug interactions of class Ili antiarrhythmic drugs[J]. Drug Saf. 2003,26(6):421 -438.
8Kounas SP, Letsas KP, Sideris A,et al. QT interval prolonga tion and torsades de pointes due to a coadministration of met ronidazole and amiodarone [J].Pacing Clin Electrophysiol. 2005,28 (5) : 472- 473.
9Bailey DG, Dresser GK. Interactions between grapefruit juice and cardiovascular drugs[J]. Am J Cardiovasc Drugs, 2004,4 (5):281- 297.
10Roten L, Schoenenberger RA, Krahenbiihl S, et al. Rhab domyolysis in association with simvastatin and amiodarone[J]. Ann Pharmacother. 2004,38(6):978-98l.
